ArticlePloS one2015

A novel GTP-binding inhibitor, FX2149, attenuates LRRK2 toxicity in Parkinson's disease models.

Tianxia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.